MediPal Holdings Corporation (TYO:7459)
2,941.50
+29.00 (1.00%)
At close: Mar 27, 2026
MediPal Holdings Market Cap
MediPal Holdings has a market cap or net worth of 602.12 billion as of March 27, 2026. Its market cap has increased by 30.16% in one year.
Market Cap
602.12B
Enterprise Value
468.97B
Revenue
3.78T
Ranking
n/a
PE Ratio
14.66
Stock Price
2,941.50
Market Cap Chart
Since June 30, 1999, MediPal Holdings's market cap has increased from 47.56B to 602.12B, an increase of 1,166.02%. That is a compound annual growth rate of 9.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 602.12B | 6.19% |
| Dec 30, 2025 | 567.02B | 14.54% |
| Dec 30, 2024 | 495.03B | 2.54% |
| Dec 29, 2023 | 482.78B | 32.07% |
| Dec 30, 2022 | 365.54B | -19.21% |
| Dec 30, 2021 | 452.47B | 11.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 14.05T |
| Takeda Pharmaceutical Company | 9.23T |
| HOYA Corporation | 9.19T |
| Otsuka Holdings | 6.02T |
| Sumitomo Pharma | 859.93B |
| Sugi Holdings | 626.89B |
| Santen Pharmaceutical | 574.83B |
| COSMOS Pharmaceutical | 528.41B |